The draft of the KDIGO 2026 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (CKD) was recently made available for public review. KDIGO invites clinicians, researchers, and other stakeholders to review the draft and provide comments to help inform the final guideline. The Guideline Work Group will review all feedback and prepare a final version of the guideline based on the comments received.
This update reflects important clinical and scientific developments since publication of the KDIGO 2022 Diabetes Guideline, and focuses on three main areas:
The guideline update follows KDIGO’s rigorous evidence-based methodology, including systematic reviews of studies published through July 2025, assessment of the certainty of evidence and strength of recommendations using the GRADE approach, and integration of new data with contemporary treatment strategies for patients with diabetes and CKD. The guideline is co-chaired by Dr. Ian de Boer (United States) and Dr. Peter Rossing (Denmark).
ADDITIONAL TOOLS & RESOURCES
(2025) KDIGO Digital Heat Map
(2023) KDIGO 2022 Diabetes Guideline Quick Reference Guide
(2023) KDIGO 2022 Diabetes in CKD Guideline Infographic Set
ANCILLARY PUBLICATIONS & COMMENTARY
Annals of Internal Medicine
CJASN
Diabetes Care
(2022) ADA-KDIGO Consensus Report on Diabetes Management in CKD
Guidelines for Primary Care (UK)
(2022) Summary of the KDIGO Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
Internal Medicine Journal (AUS)
(2026) – CARI Commentary on KDIGO 2022 Diabetes in CKD Guideline
Kidney International
(2022) ADA-KDIGO Consensus Report on Diabetes Management in CKD
GERMAN
POLISH
RUSSIAN
KDIGO 2020 DIABETES IN CKD GUIDELINE SUITE
KDIGO 2020 Diabetes Management in CKD Guideline
KDIGO 2020 Diabetes Management in CKD Guideline Executive Summary
KDIGO 2020 Diabetes Management in CKD Guideline Central Illustration
KDIGO 2020 Diabetes Management in CKD Guideline Top 10 Takeaways for Clinicians
KDIGO 2020 Diabetes Management in CKD Guideline Top 10 Takeaways for Patients
—
American Family Physician
Annals of Internal Medicine
CJASN
KDIGO 2020 DIABETES IN CKD GUIDELINE TRANSLATIONS
German
2020 – KDIGO-Leitlinie zur Behandlung des Diabetes mellitus bei chronischer Nierenerkrankung
Mandarin
2020 KDIGO 指南概要: 基于循证的CKD合并糖尿病的管理和治疗
KDIGO 2020 Diabetes in CKD Best of ADA 2020 Presentation 中文
Dr. Ian de Boer, Guideline Co-Chair
Ukranian
KDIGO 2020 DIABETES IN CKD VIDEOS & WEBINARS
DISCLAIMER: USE OF THE CLINICAL PRACTICE GUIDELINES
This Clinical Practice Guideline is based upon the best information available at the time of publication. The recommendations are designed to provide information and assist decision-making. They are not intended to define a standard of care, and should not be construed as one. Neither should they be interpreted as prescribing an exclusive course of management. Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every health care professional making use of this Guideline is responsible for evaluating the appropriateness of applying them in the setting of any particular clinical situation. The recommendations for research contained within this document are general and do not imply a specific protocol.
